V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230000520 | 230000303 | 1.74 | 83 | Not known (9) | 2015-08-06 | 2015-08-06 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | 230005102 | OXALIPLATIN + MDG |
| 230000521 | 230000303 | 1.73 | 81.8 | Palliative (P) | 2016-06-02 | 2016-06-30 | FLUOROURACIL | N | N | 230005102 | IRINOTECAN + MDG |
| 230000522 | 230000303 | 1.84 | 78.7 | Curative (C) | 2018-10-07 | 2018-10-27 | Sorafenib | N | Y | 230005102 | IRINOTECAN + MDG |
| 230000523 | 230000304 | 1.78 | 103 | Adjuvant (A) | 2014-01-17 | 2014-01-18 | Sorafenib | 02 | N | 230005219 | SORAFENIB |
| 230000524 | 230000305 | 1.85 | null | Adjuvant (A) | 2017-09-28 | 2017-10-20 | Carboplatin + Etoposide iv&po | 02 | N | 230005249 | FLUOROURACIL + MITOMYCIN + RT |
| 230000525 | 230000306 | 1.6 | 83.9 | Curative (C) | 2015-11-09 | 2015-11-17 | Oxaliplatin + Modified de Gramont | N | N | 230005256 | DOCETAXEL |
| 230000526 | 230000306 | 1.64 | 64.3 | Adjuvant (A) | 2014-08-09 | 2014-08-10 | Sorafenib | N | N | 230005256 | CARBOPLATIN + PACLITAXEL |
| 230000527 | 230000306 | null | 73.1 | Disease modification (D) | 2015-07-22 | 2015-10-13 | Capecitabine 35days + RT | null | null | 230005256 | OXALIPLATIN + MDG |
| 230000528 | 230000307 | 1.77 | 79.2 | Adjuvant (A) | 2013-11-30 | 2013-12-07 | Irinotecan + Modified De Gramont | 02 | N | 230005306 | AFATINIB |
| 230000529 | 230000308 | 1.65 | 81 | Palliative (P) | 2017-03-25 | 2017-04-05 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 230005319 | CAPECITABINE |
| 230000530 | 230000309 | 1.71 | 69.9 | Palliative (P) | 2014-06-19 | 2014-07-09 | Carboplatin + Pemetrexed | N | null | 230005329 | CAPECITABINE |
| 230000531 | 230000310 | null | 88 | Palliative (P) | 2015-11-15 | 2015-11-17 | Carboplatin AUC 2 - 5 | 2 | N | 230005331 | SORAFENIB |
| 230000532 | 230000311 | 1.64 | 64.5 | Palliative (P) | 2013-09-28 | 2013-10-01 | FLUOROURACIL + OXALIPLATIN | 2 | N | 230005374 | CARBOPLATIN + ETOPOSIDE |
| 230000533 | 230000312 | 1.62 | 64.5 | Adjuvant (A) | 2015-10-29 | 2015-11-21 | Capecitabine | 02 | N | 230005382 | CARBOPLATIN + PEMETREXED |
| 230000534 | 230001166 | 1.72 | 85.2 | Palliative (P) | 2017-06-29 | 2017-06-29 | Oxaliplatin + Modified de Gramont | N | null | 230005390 | SORAFENIB |
| 230000535 | 230000313 | null | 69.1 | Palliative (P) | null | 2017-10-02 | EC | 01 | N | 230005439 | RITUXIMAB |
| 230000536 | 230000314 | null | 33 | Curative (C) | 2018-05-19 | 2018-05-28 | RCEOP | N | N | 230005457 | CISPLATIN + DOXORUBICIN |
| 230000537 | 230000315 | 1.59 | 57.4 | Adjuvant (A) | 2015-04-09 | 2015-04-09 | Capecitabine + Oxaliplatin 21day | 02 | Y | 230005472 | CARBOPLATIN + ETOPOSIDE |
| 230000538 | 230001167 | null | 100.55 | Curative (C) | 2016-07-17 | 2016-08-01 | Capecitabine 35days + RT | null | Y | 230005495 | CAPECITABINE |
| 230000539 | 230000316 | 1.72 | 86.8 | Palliative (P) | 2018-11-03 | 2018-11-07 | PEMBROLIZUMAB | 02 | N | 230005517 | DOCETAXEL |
| 230000540 | 230001168 | 1.73 | 49.9 | Palliative (P) | 2016-01-18 | 2016-01-25 | Cetuximab + FOLFIRI cycle1 | 02 | N | 230005543 | GEMCITABINE |
| 230000541 | 230001168 | 1.57 | null | Palliative (P) | 2017-05-17 | 2017-05-24 | Carboplatin + Etoposide IV 3 day | 02 | N | 230005543 | CAPECITABINE + MITOMYCIN + RT |
| 230000542 | 230000317 | 1.55 | 49.4 | Palliative (P) | 2018-02-09 | 2018-03-03 | Capecitabine | 02 | N | 230005581 | CAP + RT |
| 230000543 | 230000318 | 1.72 | 80.7 | Not known (9) | null | 2018-01-13 | CAPECITABINE + MITOMYCIN + RT | N | N | 230005594 | CARBOPLATIN + PACLITAXEL |
| 230000544 | 230000319 | 1.56 | 72.9 | Adjuvant (A) | 2015-08-01 | 2015-08-02 | AFATINIB | 2 | null | 230005645 | VANDETANIB |
| 230000545 | 230000320 | 1.73 | 96.2 | Palliative (P) | 2018-01-25 | 2018-01-28 | Folfirinox | N | null | 230005648 | ENZALUTAMIDE |
| 230000546 | 230000321 | 1.67 | 76.7 | Adjuvant (A) | 2016-08-06 | 2016-09-22 | Capecitabine + Oxaliplatin 21day | N | N | 230005683 | CAPECITABINE + RT |
| 230000547 | 230000322 | 1.73 | 65 | null | 2017-05-23 | 2017-06-19 | Folfirinox | N | null | 230005745 | CARBOPLATIN + ETOPOSIDE |
| 230000548 | 230000322 | 0 | 50 | Adjuvant (A) | 2016-08-08 | 2016-08-16 | CARBOPLATIN + PACLITAXEL | N | N | 230005745 | SORAFENIB |
| 230000549 | 230001502 | 1.81 | 74 | Adjuvant (A) | 2016-12-26 | 2016-12-26 | Capecitabine | 02 | N | 230005780 | DOCETAXEL |
| 230000550 | 230000323 | 1.53 | 51.2 | Not known (9) | 2013-10-23 | 2013-10-24 | Fluorouracil + Folinic Acid Weekly | N | N | 230005785 | TEMOZOLOMIDE |
| 230000551 | 230000324 | null | 95.1 | Curative (C) | 2015-12-31 | 2016-10-15 | FLUOROURACIL | N | null | 230005793 | CISPLATIN + DOXORUBICIN |
| 230000552 | 230000325 | 1.83 | 102.6 | Palliative (P) | 2018-06-26 | 2018-07-18 | CAPECITABINE + OXALIPLATIN | 2 | N | 230005802 | CISPLATIN + RT |
| 230000553 | 230000326 | 1.64 | 42.9 | Palliative (P) | 2017-05-11 | 2017-05-26 | FEC 60 or 75 | N | N | 230005805 | DOCETAXEL |
| 230000554 | 230000326 | 1.8 | 85.5 | Curative (C) | 2017-09-02 | 2017-09-16 | Capecitabine 35days + RT | null | N | 230005805 | CAPECITABINE + OXALIPLATIN |
| 230000555 | 230000327 | 1.77 | 75.05 | Neo-adjuvant (N) | 2017-02-03 | 2017-02-06 | CYCLOPHOSPHAMIDE + FILGRASTIM | 02 | N | 230005832 | CISPLATIN + PEMETREXED |
| 230000556 | 230000327 | 1.65 | 58 | Palliative (P) | null | 2018-01-22 | Fluorouracil+Mitomycin+RT (Anal Ca) | Y | N | 230005832 | SORAFENIB |
| 230000557 | 230001503 | 1.9 | 81.6 | Adjuvant (A) | 2017-08-02 | 2017-08-26 | Cisplatin + Etoposide po&iv 3 day | N | N | 230005840 | CAPECITABINE + MITOMYCIN + RT |
| 230000558 | 230001503 | 1.64 | null | Curative (C) | 2017-10-11 | 2017-11-01 | Sorafenib | N | null | 230005840 | SORAFENIB |
| 230000559 | 230001503 | 1.59 | 80 | Curative (C) | 2016-02-15 | 2016-02-24 | CAPECITABINE + OXALIPLATIN | 02 | N | 230005840 | CISPLATIN + VINORELBINE |
| 230000560 | 230000328 | 1.65 | 80.4 | Adjuvant (A) | 2013-08-05 | 2013-09-01 | Capecitabine + Oxaliplatin 21day | 02 | N | 230005940 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 230000561 | 230000329 | null | null | Palliative (P) | 2018-09-24 | 2018-10-21 | Cape +Cetuximab +Oxalip (3 wk) Load | N | N | 230005941 | CARBOPLATIN + RT |
| 230000562 | 230000329 | null | 51.4 | Curative (C) | null | 2017-07-11 | Oxaliplatin + Modified de Gramont | null | Y | 230005941 | CARBOPLATIN + PACLITAXEL |
| 230000563 | 230000329 | null | 59.8 | Palliative (P) | 2014-06-01 | 2014-06-13 | Capecitabine | N | N | 230005941 | VANDETANIB |
| 230000564 | 230000330 | 1.68 | 56 | Adjuvant (A) | 2013-06-07 | 2013-06-23 | Capecitabine | 02 | null | 230006101 | CAPECITABINE |
| 230000565 | 230000331 | 1.51 | null | Not known (9) | 2012-07-15 | 2012-08-04 | Oxaliplatin + Modified de Gramont | N | N | 230006158 | PAZOPANIB |
| 230000566 | 230000332 | null | 54.85 | Adjuvant (A) | 2014-11-11 | 2014-11-30 | Docetaxel 75mg/m2 (21 day) | N | N | 230006179 | DOXORUBICIN |
| 230000567 | 230000333 | 1.63 | 79.05 | Neo-adjuvant (N) | 2017-04-04 | 2017-04-14 | Fluorouracil + Folinic Acid Weekly | N | Y | 230006180 | FLUOROURACIL + MITOMYCIN + RT |
| 230000568 | 230000333 | 1.64 | 145.8 | Palliative (P) | 2015-08-07 | 2015-08-21 | FEC 60 or 75 | 02 | N | 230006180 | CAPECITABINE |
| 230000569 | 230000334 | 1.71 | 0 | Palliative (P) | 2015-10-21 | 2015-10-21 | SCOT TRIAL | 2 | N | 230006216 | CARBOPLATIN + PACLITAXEL |